Eve Burstein
Stock Analyst at Bernstein
(2.63)
# 2,023
Out of 5,128 analysts
24
Total ratings
46.15%
Success rate
24.02%
Average return
Main Sectors:
Stocks Rated by Eve Burstein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Market Perform | $145 → $125 | $147.60 | -15.31% | 5 | Apr 16, 2025 | |
| NTRA Natera | Maintains: Outperform | $160 → $200 | $248.74 | -19.59% | 4 | Jan 10, 2025 | |
| RVTY Revvity | Maintains: Outperform | $150 → $145 | $105.05 | +38.03% | 2 | Nov 5, 2024 | |
| WAT Waters | Maintains: Market Perform | $345 → $360 | $400.54 | -10.12% | 2 | Nov 4, 2024 | |
| EXAS Exact Sciences | Maintains: Outperform | $75 → $90 | $101.65 | -11.46% | 2 | Oct 30, 2024 | |
| GH Guardant Health | Maintains: Outperform | $40 → $35 | $112.33 | -68.84% | 2 | Oct 30, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Market Perform | $625 → $620 | $620.72 | -0.12% | 3 | Oct 24, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Outperform | $9 → $2.5 | $2.08 | +20.19% | 2 | Apr 18, 2024 | |
| AVTR Avantor | Initiates: Market Perform | $22 | $12.27 | +79.30% | 1 | Sep 28, 2023 | |
| ILMN Illumina | Initiates: Underperform | $111 | $147.11 | -24.55% | 1 | Sep 28, 2023 |
Agilent Technologies
Apr 16, 2025
Maintains: Market Perform
Price Target: $145 → $125
Current: $147.60
Upside: -15.31%
Natera
Jan 10, 2025
Maintains: Outperform
Price Target: $160 → $200
Current: $248.74
Upside: -19.59%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $150 → $145
Current: $105.05
Upside: +38.03%
Waters
Nov 4, 2024
Maintains: Market Perform
Price Target: $345 → $360
Current: $400.54
Upside: -10.12%
Exact Sciences
Oct 30, 2024
Maintains: Outperform
Price Target: $75 → $90
Current: $101.65
Upside: -11.46%
Guardant Health
Oct 30, 2024
Maintains: Outperform
Price Target: $40 → $35
Current: $112.33
Upside: -68.84%
Thermo Fisher Scientific
Oct 24, 2024
Maintains: Market Perform
Price Target: $625 → $620
Current: $620.72
Upside: -0.12%
Pacific Biosciences of California
Apr 18, 2024
Maintains: Outperform
Price Target: $9 → $2.5
Current: $2.08
Upside: +20.19%
Avantor
Sep 28, 2023
Initiates: Market Perform
Price Target: $22
Current: $12.27
Upside: +79.30%
Illumina
Sep 28, 2023
Initiates: Underperform
Price Target: $111
Current: $147.11
Upside: -24.55%